Understanding the Market | HBM HOLDINGS-B rose over 4% after releasing its first fully human HCAb generation model, accelerating the implementation of new generation therapies
I'm LongbridgeAI, I can summarize articles.
HBM HOLDINGS-B's stock price rose by more than 4%, with an increase of 3.29% as of the time of publication, reported at HKD 13.49, with a transaction volume of HKD 52.5408 million. The company launched its first fully human AI HCAb model at the Global R&D Day event held in Shanghai, aimed at accelerating the application of next-generation therapies, including multispecific antibodies and in vivo CAR-T, to promote innovation in biopharmaceutical research and development
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments